Download PDF
Dtsch Med Wochenschr 2015; 140(07): 496-499
DOI: 10.1055/s-0041-101153
Klinischer Fortschritt
Nephrologie
© Georg Thieme Verlag KG Stuttgart · New York

Primäre arterielle Hypertonie – Update 2015

Primary arterial hypertension – update 2015
Bernd Sanner
1   Medizinische Klinik, Agaplesion Bethesda Krankenhaus Wuppertal
,
Martin Hausberg
2   Medizinische Klinik I, Städtisches Klinikum Karlsruhe
› Author Affiliations
Further Information

Publication History

Publication Date:
31 March 2015 (online)

Also available at
   Permissions and Reprints

Zusammenfassung

Epidemiologische Untersuchungen zeigen für Deutschland eine deutlich bessere Behandlungsrate und Kontrolle der arteriellen Hypertonie. Ein Zusammenhang zwischen Kochsalzkonsum und Höhe von systolischem und diastolischem Blutdruck konnte nachgewiesen werden. Für die therapeutischen Optionen bleibt der Stellenwert der renalen Denervierung noch unklar.

Abstract

The rate of treatment and control increased significantly in Germany during the last years. Severeal studies could demonstrate an association of sodium consumption with blood pressure. The status of renal denervation in the treatment of high blood pressure remains unclear.

Schlüsselwörter

arterielle Hypertonie - Salz - Sympathikus-Denervierung

Keywords

systemic hypertension - salt - sympathetic ablation
 

  • Literatur

  • 1 Acelajado MC, Pisoni R, Dudenbostel T et al. Refractory hypertension: definition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich) 2012; 14: 7-12
    CrossrefPubMedSearch in Google Scholar
  • 2 Bhatt DL, Kandzari DE, O’Neill WW et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401
    CrossrefPubMedSearch in Google Scholar
  • 3 Brinkmann J, Heusser K, Schmidt BM et al. Catheter-based renal nerve ablation and centrally generated sympathetic activity in difficult-to-control hypertensive patients: prospective case series. Hypertension 2012; 60: 1485-1490
    CrossrefPubMedSearch in Google Scholar
  • 4 Diederichs C, Neuhauser H. Regional variations in hypertension prevalence and management in Germany: results from the German Health Interview and Examination Survey (DEGS1). J Hypertens 2014; 32: 1405-1414
    CrossrefPubMedSearch in Google Scholar
  • 5 Esler MD, Krum H, Sobotka P et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376: 1903-1909
    CrossrefPubMedSearch in Google Scholar
  • 6 Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). Am J Hypertens 2012; 25: 1-15
    PubMedSearch in Google Scholar
  • 7 Hering D, Marusic P, Walton AS et al. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension. Hypertension 2014; 64: 118-124
    CrossrefPubMedSearch in Google Scholar
  • 8 Krum H, Schlaich MP, Sobotka PA et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014; 383: 622-629
    CrossrefPubMedSearch in Google Scholar
  • 9 Mahfoud F, Vonend O, Bruck H et al. Interventionelle renale Sympathikusdenervation zur Behandlung der therapieresistenten Hypertonie. Dtsch Med Wochenschr 2011; 136: 2418
    Thieme ConnectPubMedSearch in Google Scholar
  • 10 Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH / ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357
    CrossrefPubMedSearch in Google Scholar
  • 11 McManus RJ, Mant J, Haque MS et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA 2014; 312: 799-808
    CrossrefPubMedSearch in Google Scholar
  • 12 McMurray JJ, Packer M, Desai AS et al. Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure. N Engl J Med 2014; 371: 993-1004
    CrossrefPubMedSearch in Google Scholar
  • 13 Mente A, O’Donnell MJ, Rangarajan S et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med 2014; 371: 601-611
    CrossrefPubMedSearch in Google Scholar
  • 14 Mozaffarian D, Fahimi S, Singh GM et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med 2014; 371: 624-634
    CrossrefPubMedSearch in Google Scholar
  • 15 Neuhauser HK, Adler C, Rosario AS et al. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11. J Hum Hypertens 2014;
    PubMedSearch in Google Scholar
  • 16 O’Donnell MJ, Mente A, Rangarajan S et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med 2014; 371: 612-623
    CrossrefPubMedSearch in Google Scholar
  • 17 Oparil S. Low Sodium Intake – Cardiovascular Health Benefit or Risk?. N Engl J Med 2014; 371: 677-679
    CrossrefPubMedSearch in Google Scholar
  • 18 Sundström J, Arima H, Woodward M et al. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 2014; 384: 591-599
    CrossrefPubMedSearch in Google Scholar
  • 19 Vonend O, Böhm M, Eckert S et al. Renale Denervation bei nicht-kontrollierter arterieller Hypertonie. Dtsch Med Wochenschr 2015; 140: 363
    PubMedSearch in Google Scholar